VINCENT NEALEY: Open Payments
NPI 1124748843 · CINCINNATI,, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 73 payments from 11 companies in 2025. Trend: 2023 $53 · 2024 $1,193 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $326 |
| Novo Nordisk Inc | 11 | $270 |
| AstraZeneca Pharmaceuticals LP | 5 | $180 |
| Otsuka America Pharmaceutical, Inc. | 9 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $100 |
| Lilly USA, LLC | 4 | $81 |
| Antares Pharma, Inc. | 4 | $81 |
| Astellas Pharma US Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: Ozempic, AIRSUPRA, VRAYLAR, REXULTI, QULIPTA, CAPLYTA, MOUNJARO, XYOSTED.
Industry payments across OH — which companies pay providers there.
